Reversible Left Ventricular Dysfunction Associated with Guillain-Barré Syndrome —Expression of Catecholamine Cardiotoxicity?—

Japanese Circulation Journal

Volumn 59, Issue 4, 1995, Pages 236-240

  Iga, Kanji ^a   Himura, Yoshihiro ^a   Izumi, Chisato ^a   Miyamoto, Tadashi ^a   Kijima, Kazuhisa ^a   Gen, Hiromitsu ^a   Konishi, Takashi ^a  

^a TENRI HOSPITAL   (Japan)

Author keywords

Catecholamine; Guillain Barr syndrome; Left ventricular wall motion; Metaiodobenzylguanidine (MIBG); Myocardial scintigram

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ADRENALIN; C REACTIVE PROTEIN; CREATINE KINASE; NORADRENALIN;

AGED; ARTICLE; CASE REPORT; CATECHOLAMINE METABOLISM; FEMALE; GUILLAIN BARRE SYNDROME; HEART LEFT VENTRICLE FAILURE; HUMAN; SCINTIGRAPHY;

EID: 0028997946     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.59.236     Document Type: Article

References (6)

1. Singh NK, Jaiswal AK, Misra S, Srivastava PK: Assessment of autonomic dysfunction in Guillain-Barrr syndrome and its prognostic implications. Act Neurol Scand 1987; 75: 101-105.
2. Oakley CM: The heart in the Guillain-Barre syndrome. Br Med J 1984; 288: 94.
3. Narayan D, Huang MTC, Mathew PK: Bradycardia and asystole requiring permanent pacemaker in Guillain-Barre syndrome. Am Heart J 1984; 108: 426-427.
4. Dyck PJ, Thomas PK, W.B. eds. Peripheral neuropathy. 3rd ed. Philadelphia, Saunders, 1993.
5. Iga K, Gen H, Tomonaga G, Matsumura T, Hori K: Reversible left ventricular wall motion impairment caused by pheochromocytoma. Jpn Circ J 1989; 53: 813-818.
6. Axcelrod J: The fate of noradrenaline in the sympathetic norepinephrine neuron. Harvey Lect 1973; 67: 175-197.